Brief: Rakovina Therapeutics Announces Q3 2022 Financial Results And Provides Corporate Update
17/11/2022 14:17
Nov 17 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS INC. ANNOUNCES Q3 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* RAKOVINA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.01
Source text for Eikon: ID:nGNX2xvQVL
Further company coverage: RKV.V
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration